nineteen patients with rheumatoid arthritis entered a double-blind cross-over study , comparing a new anti-inflammatory agent isoxepac , 200 mg three times daily , with aspirin 1.2 g three times daily .
C0003873
rheumatoid arthritis
C0004057
aspirin